Eco Animal Health Group PLC (LSE:EAH) - Share price


Stock Report

Eco Animal Health Group PLC EAH

Last Price
GBX162.50

Day Change
-2.50|-1.52%

As of 03/12/2021
15:48:38 GMT | GBX
Minimum 15 Minutes Delay.

Last Close165.00p
Day Range156.00 - 165.80
Mkt Cap110.00Mil
52-Wk Range140.00 - 405.00
Yield %0.62
ISINGB0032036807
Volume128,565
P/E19.72
P/S0.01
P/CF0.09

Share Price

Total Returns 03/12/2021

 Chg (%)  
More ...
Eco Animal Health Group PLC-35.64 
FTSE 100 TR GBP-1.66
 
Financials
201920202021
More ...
Income Statement
Turnover67.2572.11105.61
Operating Profit10.066.0420.00
Net Profit8.855.4916.65
Reported EPS10.715.5412.07
Balance Sheet
Current Assets60.9659.4176.45
Non Current Assets38.7940.5840.17
Total Assets99.7599.99116.62
Current Liabilities15.0917.8518.40
Total Liabilities16.5319.5419.79
Total Equity83.2280.4596.83
Cash Flow
Operating Cash Flow7.145.4715.75
Net Change in Cash-3.97-7.0510.36
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/11/2021PurchaseMr. Marc Denham Loomes150.4033,24449,999.00
30/11/2021PurchaseMr. Christopher John Wilks150.6416,59524,999.00
28/07/2021PurchaseDr. Frank Murdoch Armstrong324.003,0009,720.00
28/07/2021PurchaseMr. Christopher John Wilks330.007,50024,750.00

Company Profile

Eco Animal Health Group PLC is engaged in the manufacture and marketing of animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. Its geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 26/07/2022

Final Results
Ratios
Comp
More ...
PER (E)19.11
Div Yld (E)0.63
PEG (E)0.00
ROCE20.85
Op Mrgn0.19
EPS Grwth1.18
Dividends
PreviousLatest
More ...
Record Date27/09/1924/09/21
Ex-Div26/09/1923/09/21
Paid16/10/1922/10/21
Amnt11.041.00
Directors
More ...
Non-Executive DirectorDr. Frank Murdoch Armstrong
Executive Director, Chief Executive OfficerMr. Marc Denham Loomes
Executive Director, Chief Financial Officer and Company SecretaryMr. Christopher John Wilks
Non-Executive DirectorMr. Anthony Paul Rawlinson
Non-Executive Director, ChairmanDr. Andrew Alfred Jones PhD
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.